Simian immunodeficiency virus DNA vaccine trial in macaques.
about
Genome-wide screening, cloning, chromosomal assignment, and expression of full-length human endogenous retrovirus type KIncreased immune response elicited by DNA vaccination with a synthetic gp120 sequence with optimized codon usageSequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifsSynthetic DNA vaccine strategies against persistent viral infectionsEnhancement of immunoglobulin G2a and cytotoxic T-lymphocyte responses by a booster immunization with recombinant hepatitis C virus E2 protein in E2 DNA-primed miceTetraspanins in viral infections: a fundamental role in viral biology?Naked DNA vaccines expressing the prM and E genes of Russian spring summer encephalitis virus and Central European encephalitis virus protect mice from homologous and heterologous challengeComparison of immunity generated by nucleic acid-, MF59-, and ISCOM-formulated human immunodeficiency virus type 1 vaccines in Rhesus macaques: evidence for viral clearance.Simultaneous induction of multiple antigen-specific cytotoxic T lymphocytes in nonhuman primates by immunization with a mixture of four Plasmodium falciparum DNA plasmidsRecombinant vaccine-induced protection against the highly pathogenic simian immunodeficiency virus SIV(mac251): dependence on route of challenge exposure.DNA vaccination affords significant protection against feline immunodeficiency virus infection without inducing detectable antiviral antibodies.Studies of the neutralizing activity and avidity of anti-human immunodeficiency virus type 1 Env antibody elicited by DNA priming and protein boosting.Enhanced T-cell immunogenicity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowlpox virus.Simian immunodeficiency virus (SIV) gag DNA-vaccinated rhesus monkeys develop secondary cytotoxic T-lymphocyte responses and control viral replication after pathogenic SIV infection.Vaccine protection against simian immunodeficiency virus by recombinant strains of herpes simplex virus.Immunogenicity of a human immunodeficiency virus (HIV) polytope vaccine containing multiple HLA A2 HIV CD8(+) cytotoxic T-cell epitopesDNA vaccines expressing different forms of simian immunodeficiency virus antigens decrease viremia upon SIVmac251 challenge.Multiple effects of codon usage optimization on expression and immunogenicity of DNA candidate vaccines encoding the human immunodeficiency virus type 1 Gag protein.Protection against simian immunodeficiency virus vaginal challenge by using Sabin poliovirus vectorsInduction of neutralization antibodies in mice by Dengue-2 envelope DNA vaccines.DNA immunization against herpes simplex virus: enhanced efficacy using a Sindbis virus-based vectorControl of viremia and prevention of simian-human immunodeficiency virus-induced disease in rhesus macaques immunized with recombinant vaccinia viruses plus inactivated simian immunodeficiency virus and human immunodeficiency virus type 1 particlesEnhancement of antibodies to the human immunodeficiency virus type 1 envelope by using the molecular adjuvant C3d.Attenuated Salmonella enterica serovar Typhi and Shigella flexneri 2a strains mucosally deliver DNA vaccines encoding measles virus hemagglutinin, inducing specific immune responses and protection in cotton rats.Unique V3 loop sequence derived from the R2 strain of HIV-type 1 elicits broad neutralizing antibodies.Abeta DNA vaccination for Alzheimer's disease: focus on disease prevention.Enhanced avidity maturation of antibody to human immunodeficiency virus envelope: DNA vaccination with gp120-C3d fusion proteins.Augmentation of immune responses to HIV-1 and simian immunodeficiency virus DNA vaccines by IL-2/Ig plasmid administration in rhesus monkeys.DNA vaccines against human immunodeficiency virus type 1 in the past decade.Expression of human endogenous retrovirus type K envelope glycoprotein in insect and mammalian cells.Induction of vigorous cytotoxic T-lymphocyte responses by live attenuated simian immunodeficiency virus.Immune response to a hepatitis B DNA vaccine in Aotus monkeys: a comparison of vaccine formulation, route, and method of administration.Multigene DNA priming-boosting vaccines protect macaques from acute CD4+-T-cell depletion after simian-human immunodeficiency virus SHIV89.6P mucosal challengeEnhancement of feline immunodeficiency virus (FIV) infection after DNA vaccination with the FIV envelope.Enhancing efficacy of HIV gag DNA vaccine by local delivery of GM-CSF in murine and macaque models.Rationale for peptide and DNA based epitope vaccines for Alzheimer's disease immunotherapy.A consecutive priming-boosting vaccination of mice with simian immunodeficiency virus (SIV) gag/pol DNA and recombinant vaccinia virus strain DIs elicits effective anti-SIV immunity.DNA Immunization for HIV Vaccine Development.Vaccination of macaques against pathogenic simian immunodeficiency virus with Venezuelan equine encephalitis virus replicon particles.Evolution of envelope-specific antibody responses in monkeys experimentally infected or immunized with simian immunodeficiency virus and its association with the development of protective immunity.
P2860
Q24527314-4B680B5E-21C8-450F-9D18-7768A7339C11Q24531468-9E82EB69-3C26-4FA6-96E1-54EC8105BAECQ24644853-ED5016F7-575B-4E54-A8E7-63E3CC67C6F1Q27016078-92DBA697-EA6F-403B-B9B8-6CA636A3309AQ27469642-13384E90-1704-4BDB-8F3E-A026955E68FCQ27470936-C816075B-1938-4E29-8F5D-BD1BF3BB3B9CQ27485866-E4498A71-ADA0-4D78-962D-50A2E8BBCD54Q33645053-3AC70FCA-6761-498C-BFD5-687B8256E4E3Q33761524-684DE029-E865-4CA8-99B5-930C453D29C0Q33782797-D78F0FBA-CFE3-4E05-AA0C-D01DADDDE42FQ33783841-2B64CE41-5226-4429-93A9-FBDDC03FF478Q33785383-EF7F9AEE-D680-417C-9565-92D93699658BQ33786257-5D952D73-90D8-42BF-8A70-11D72E0F3160Q33809753-87F9B4DC-AA09-4DB1-8C9A-7D575B695E70Q33810277-F0D538E2-AD10-4AFA-BA98-7990BA2FBC10Q33814863-712E2A3C-C378-44C3-8CD1-5D59ADA371ABQ33843297-D7EC1E80-B80F-4524-BBBF-7EC3E12392AEQ33849127-49497035-B421-4BC9-BD65-D9B98788A451Q33852720-7D1A168B-EF7F-47ED-9371-AD47FF7D9AFBQ33961878-91AC2CE7-4541-448E-8274-8BF40E32FF75Q34069023-C0D8FB77-0171-4ECD-A9B7-DCE4177105C0Q34465510-F09585FE-9601-4FDA-ABEB-AAE9C8CF1947Q34466693-47BC3DC5-3DD7-481C-8E41-EC1EAD393055Q34976024-F4055609-3A1C-48D9-BE4F-1ED72DE4A842Q34999724-A62769A0-D460-440A-9A44-8E458F03786CQ35156471-6089E15D-011E-4C20-BDBA-13C348A37221Q35613328-43E6943F-2491-4DDC-BF41-BEF17AF18F43Q35674907-B22350D9-D37D-4026-A08F-70B12E7C67FFQ35745831-7D059128-2499-43D6-A1C9-6B69CADFD514Q35880467-35B0290D-CBDC-4CB9-B6DE-620289E9BF24Q35895851-C41070CD-B2CA-4AD5-AA4C-92312DFFEDA2Q36438213-4FFC81B4-67A3-42C9-A028-2D52970F2FA5Q36538907-AC95300F-3D43-4FD7-99AD-FB0126BD28BEQ36549107-C5D5097D-46FD-4751-895A-C6F5EDBB0B6FQ36647936-D12F3A88-04A1-4489-95FE-7FBDDB8489F9Q37438261-B2C9C7D8-FCD0-4B15-8525-0840E6A13D29Q37492797-32AF9313-DF03-4093-9762-5267AD230216Q38581981-7348486B-03B1-45BD-9491-02E8FBE683ACQ39588679-5B022E3C-9814-420B-96BC-B9567A939590Q39880154-99FABBEC-2FD9-44F4-ABDD-036AE8B619E3
P2860
Simian immunodeficiency virus DNA vaccine trial in macaques.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Simian immunodeficiency virus DNA vaccine trial in macaques.
@ast
Simian immunodeficiency virus DNA vaccine trial in macaques.
@en
type
label
Simian immunodeficiency virus DNA vaccine trial in macaques.
@ast
Simian immunodeficiency virus DNA vaccine trial in macaques.
@en
prefLabel
Simian immunodeficiency virus DNA vaccine trial in macaques.
@ast
Simian immunodeficiency virus DNA vaccine trial in macaques.
@en
P2093
P2860
P1433
P1476
Simian immunodeficiency virus DNA vaccine trial in macaques
@en
P2093
D C Montefiori
H L Robinson
J C Santoro
J I Mullins
J R Haynes
P2860
P304
P407
P577
1996-06-01T00:00:00Z